BN-108

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBN-108

Drug Alias NameBN-108

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionApoptosis stimulantsMammalian target of Rapamycin (mTORC1) inhibitors

TargetsMammalian target of Rapamycin (mTORC1)

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBionovo Gmbh

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBionovo Gmbh

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

ATC CodeN/A